Amarin Corp Plc (AMRN)

[couldbebetter]

BB, My apologies if my questions/comments come off to some as wining,
I am not.

HLS says they will hire a sales force. Perhaps they will sell the
rights to BP as I don't see how Vascepa fits in with their mix of
other drugs and/or drugs under development.

Any deal that AMRN does, be it a BO or JV, would normally be done
by a company with a strong Cardiovascular sales team and product mix.
That is what made the HLS deal so strange, it has neither.

The Vascepa commercial AMRN is now using mentions "a new indication"
being careful not to say Cardiovascular Disease. Seams strange that
should be the case being over a year since R-I results. Who would
have predicted that?